StonvexLoading…
StonvexStonvexStonvexCore line items from ARKO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.77B | $7.64B | $5.85B | $3.83B |
Operating Income | $10.04M | $102.30M | $80.85M | $44.93M |
Net Income | $-6.64M | $22.74M | $20.89M | $7.43M |
EPS (Diluted) | $-0.07 | $0.15 | $0.14 | $0.04 |
Total Assets | $3.58B | $3.53B | $3.59B | $3.61B |
Total Liabilities | $3.02B | $3.17B | $3.21B | $3.24B |
Cash & Equivalents | $272.12M | $305.00M | $306.93M | $293.68M |
Free Cash Flow OCF − CapEx | $-11.61M | $65.30M | $50.37M | $25.85M |
Shares Outstanding | 112.18M | 110.86M | 112.38M | 113.31M |